Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al
Neurons containing hypocretin (Orexin) project to multiple neuronal systems
Table 2 summarizes the cardiovascular risk-relevant outcomes of large clinical trials such as the Diabetes therapy Utilization: Researching changes in A1c, weight and other factors Through Intervention with exenatide Once weekly (DURATION) trials of exenatide once-weekly, the Liraglutide Effect and Action in Diabetes (LEAD) studies of liraglutide, the Assessment of Weekly Administration of LY2189265 in Diabetes-1 (AWARD) studies of dulaglutide, the HARMONY studies of albiglutide, and the GetGoal studies of lixisenatide
It's the same active pharmaceutical ingredient, formulated by experts in a controlled, sterile environment